Tesofensine differs from many monoamine-reuptake research compounds in that it is studied as a triple inhibitor — acting at DAT, NET, and SERT — whereas many reference inhibitors target only one or two transporters. This guide compares the categories.
Single- vs multi-transporter inhibitors
Some research inhibitors are selective for one transporter (e.g. a selective serotonin transporter inhibitor); others act at two or three. Tesofensine is studied across all three monoamine transporters.
Why the distinction matters in research
The transporter-selectivity profile shapes which assay systems a compound is studied in and how results are interpreted. A triple-transporter profile means a researcher may test it against DAT, NET, and SERT lines separately.
Comparison table
| Profile | Transporter targets | Typical assay use |
|---|---|---|
| Selective inhibitor | One (e.g. SERT) | Single-transporter line |
| Dual inhibitor | Two | Two lines |
| Tesofensine | DAT, NET, SERT | All three lines |
Source tesofensine with a batch COA for reproducible comparisons.
Related research guides
- Tesofensine: monoamine-transporter research profile
- Tesofensine structure & transporter targets
- Sourcing tesofensine (COA, purity)
- Tesofensine in-vitro assay design
Research-use note
All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.
